The objective of this Fund is to achieve capital growth through investment in securities of European companies.
Name | % Net Assets |
---|---|
Nestle S.A. | 4.1% |
Roche Holding AG | 2.7% |
Total S.A. | 2.6% |
Novartis AG | 2.5% |
BASF SE | 2.0% |
ENI S.p.A. | 1.9% |
Sanofi S.A. | 1.6% |
Daimler AG | 1.6% |
Danone S.A. | 1.5% |
SAP AG | 1.5% |
Key | % Net Assets |
---|---|
Nestle S.A. | 4.1% |
Roche Holding AG | 2.7% |
Total S.A. | 2.6% |
Novartis AG | 2.5% |
Other | 88.1% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 29/08/1997 |
---|---|
Fund Manager | Batterymarch Financial Management |
TER | 2.02 (28-Feb-2013) |
Minimum Investment | |
---|---|
Initial | 3000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research